Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
filingDate |
1993-08-16^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-11-04^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_082f68eb6a9c0692af09cb7fe5135de5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928492145ce1bec629c90b2a095eb267 |
publicationDate |
1998-11-04^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-0585705-B1 |
titleOfInvention |
Use of monoclonal antibodies to TNF to treat bacterial meningitis |
abstract |
Bacterial meningitis infection in a mammal is treated by intravenous infusion of therapeutically effective amounts of monoclonal antibodies which bind to tumor necrosis factor alpha. Treatment can be initiated up to five hours after bacterial challenge and is preferably in combination with an antibiotic selected from cephalosporins and aminoglycosides. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9295725-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9061005-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8795670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9302011-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9114166-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961974-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820169-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916157-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916158-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9499615-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9327032-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9289497-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7815909-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8961973-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8940305-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9272041-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9272042-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932591-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11124565-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802100-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8911741-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802101-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802102-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9220781-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9187559-B2 |
priorityDate |
1992-08-28^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |